News

Filter

Current filters:

IpsenDiabetes

Blow for Ipsen as Roche drops taspoglutide, but good news on IB1001, as French drugmaker posts 5% rise in 2010 sales

03-02-2011

French drugmaker Ipsen (Euronext: IPN) suffered a significant setback yesterday, when Swiss major Roche…

DiabetesFinancialIpsenLicensingPharmaceuticalResearchRochetaspoglutide

Roche/Ipsen’s diabetes drug taspoglutide stumbles on safety grounds, meaning delay in approval

21-06-2010

The diabetes drug candidate taspoglutide, under development by Swiss drug major Roche and France’s…

DiabetesIpsenNovo NordiskPharmaceuticalResearchRochetaspoglutideVictoza

COMPANY SPOTLIGHT

Menarini

Back to top